QuVa Pharma, Inc. recalls R.E.C.K. (Ropivacaine HCl
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Presence of Particulate Matter
- Products
-
- R.E.C.K. (Ropivacaine HCl
- Company
- QuVa Pharma, Inc.
- Where it was sold
-
U.S. Nationwide
Nationwide
- Units affected
- 75,885 syringes
- About this recall
- R.E.C.K. (Ropivacaine HCl, EPINEPHrine, CloNIDine HCl, and Ketorolac Tromethamine) in Sodium Chloride Solution, Total Volume: 50 mL syringe. INJECTION FOR PERIARTICULAR USE; Not for IV Use. THIS IS A COMPOUNDED DRUG. QuVA Pharma, 1075 West Park One Drive, Suite 100, Sugar Land, TX 77478. NDC 70092-1433-50